4.7 Article

NEDD4 Regulates PAX7 Levels Promoting Activation of the Differentiation Program in Skeletal Muscle Precursors

期刊

STEM CELLS
卷 33, 期 10, 页码 3138-3151

出版社

WILEY
DOI: 10.1002/stem.2125

关键词

Pax7; Nedd4; Satellite cells; Skeletal muscle; Proteasome; Ubiquitin

资金

  1. National Fund for Scientific and Technological Development (FONDECYT) [1130631]
  2. International Research Visit Fellowship from Fulbright Commission
  3. CONICYT [AT-24121135]
  4. Institutional Fellowship for graduate students (VRI-PUC)
  5. National Doctoral Fellowship, CONICYT
  6. NIH [AR062836, P41 GM103533, R01 MH067880, AR049446]
  7. UCLA/NHLBI Proteomics Centers [HHSN268201000035C]

向作者/读者索取更多资源

The transcription factor Pax7 regulates skeletal muscle stem cell (satellite cells) specification and maintenance through various mechanisms, including repressing the activity of the muscle regulatory factor MyoD. Hence, Pax7-to-MyoD protein ratios can determine maintenance of the committed-undifferentiated state or activation of the differentiation program. Pax7 expression decreases sharply in differentiating myoblasts but is maintained in cells (re) acquiring quiescence, yet the mechanisms regulating Pax7 levels based on differentiation status are not well understood. Here we show that Pax7 levels are directly regulated by the ubiquitin-ligase Nedd4. Our results indicate that Nedd4 is expressed in quiescent and activated satellite cells, that Nedd4 and Pax7 physically interact during early muscle differentiation-correlating with Pax7 ubiquitination and decline-and that Nedd4 loss of function prevented this effect. Furthermore, even transient nuclear accumulation of Nedd4 induced a drop in Pax7 levels and precocious muscle differentiation. Consequently, we propose that Nedd4 functions as a novel Pax7 regulator, which activity is temporally and spatially controlled to modulate the Pax7 protein levels and therefore satellite cell fate.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据